Evidence map›Paper›PMID 33501422›Full record

ArticleBrain communications2021

Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival.

Wouter B L van den Bossche, Arnaud J P E Vincent, Cristina Teodosio, Jeroen Koets, Aladdin Taha, Anne Kleijn, Sandra de Bruin, Willem A Dik, Daniela Damasceno, Julia Almeida and 6 more

Abstract read
In one paragraph

Article in Brain communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients.International journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Wouter B L van den BosscheDepartment of Neurosurgery, Brain Tumour Center, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-2740-8490
Arnaud J P E VincentDepartment of Neurosurgery, Brain Tumour Center, Erasmus MC, Rotterdam, The Netherlands.
Cristina TeodosioDepartment of Immunology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-2097-7199
Jeroen KoetsDepartment of Immunology, Erasmus MC, Rotterdam, Netherlands.
Aladdin TahaDepartment of Immunology, Erasmus MC, Rotterdam, Netherlands.ORCID 0000-0002-1300-7477
Anne KleijnDepartment of Neurosurgery, Brain Tumour Center, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-9245-7205
Sandra de BruinDepartment of Immunology, Leiden University Medical Center, Leiden, Netherlands.
Willem A DikDepartment of Immunology, Erasmus MC, Rotterdam, Netherlands.
Daniela DamascenoCytometry Service and Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL), University of Salamanca, IBSAL and CIBERONC, Salamanca, Spain.
Julia AlmeidaCytometry Service and Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL), University of Salamanca, IBSAL and CIBERONC, Salamanca, Spain.
Diederik W J DippelDepartment of Neurology, Erasmus MC, Rotterdam, Netherlands.ORCID 0000-0002-9234-3515
Clemens M F DirvenDepartment of Neurosurgery, Brain Tumour Center, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-0713-2722
Alberto OrfaoCytometry Service and Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL), University of Salamanca, IBSAL and CIBERONC, Salamanca, Spain.
Martine L M LamfersDepartment of Neurosurgery, Brain Tumour Center, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0001-7745-9029
Jacques J M van DongenDepartment of Immunology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-3650-7087
TiMaScan Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosis and monitoring of primary brain tumours, brain metastasis and acute ischaemic stroke all require invasive, burdensome and costly diagnostics, frequently lacking adequate sensitivity, particularly during disease monitoring. Monocytes are known to migrate to damaged tissues, where they act as tissue macrophages, continuously scavenging, phagocytizing and digesting apoptotic cells and other tissue debris. We hypothesize that upon completion of their tissue-cleaning task, these tissue macrophages might migrate via the lymph system to the bloodstream, where they can be detected and evaluated for their phagolysosomal contents. We discovered a blood monocyte subpopulation carrying the brain-specific glial fibrillary acidic protein in glioma patients and in patients with brain metastasis and evaluated the diagnostic potential of this finding. Blood samples were collected in a cross-sectional study before or during surgery from adult patients with brain lesions suspected of glioma. Together with blood samples from healthy controls, these samples were flowing cytometrically evaluated for intracellular glial fibrillary acidic protein in monocyte subsets. Acute ischaemic stroke patients were tested at multiple time points after onset to evaluate the presence of glial fibrillary acidic protein-carrying monocytes in other forms of brain tissue damage. Clinical data were collected retrospectively. High-grade gliomas (

Indexed as

acute ischemic strokegliomametastatic CNS tumourminimal invasive diagnosticsneuroimmunology

Identifiers

PMID33501422
PMCPMC7811761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.